查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2004022

固化剂市场：按类型、应用、终端用户产业和形态划分－2026-2032年全球市场预测

Curing Agent Market by Curing Agent Type, Application, End Use Industry, Form - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年硬化剂市值为88.7亿美元，预计到2026年将成长至92.4亿美元，复合年增长率为5.82%，到2032年将达到131.9亿美元。

主要市场统计数据
基准年 2025 88.7亿美元
预计年份：2026年 92.4亿美元
预测年份 2032 131.9亿美元
复合年增长率 (%) 5.82%

这本权威的入门书籍概述了固化剂的化学演变、应用要求、供应链影响以及影响产业决策的策略重点。

固化剂市场的发展趋势体现了化学技术创新、应用主导的性能要求以及不断变化的监管和贸易环境的融合。近年来，製造商和化合物设计人员越来越重视缩短固化时间、提高热性能和机械性能以及更好地符合环境法规。这种环境推动了关键固化化学领域的产品差异化，并进一步提高了对特定应用配方的关注，例如需要更高耐化学性的涂料、需要更高黏接强度的黏合剂，以及必须平衡加工窗口和最终用途特性的复合材料基体。

对技术、法规和供应链驱动因素进行前瞻性审查，全面重组固化剂的开发、采购和商业化策略。

固化剂产业正经历一场变革，这场变革正在重塑传统的价值链，其驱动力来自于技术、监管和终端应用领域的转变。首先，由于电气化和轻量化的发展，性能优化日益受到重视。能够实现高热稳定性、增强对新型基材的黏合性以及缩短固化週期的配方正成为优先考虑的对象。因此，开发平臺目前主要集中在多功能化学技术和混合固化方法，这些技术和方法既能满足严格的机械和热性能要求，又能应对现代生产效率的限制。

详细检验关税到 2025 年的累积影响，以及贸易措施如何促进供应链中的回流、供应商替代和适应性创新。

关税措施和贸易政策调整已成为影响整个硬化剂生态系统原料流动、采购效率和竞争地位的关键工具。 2025年实施的政策变化已导致成本结构重组，并引发供应商和消费者的策略性回应。对许多製造商而言，日益收紧的关税环境凸显了供应基地地域多元化的重要性，并提升了近岸外包作为降低跨洋供应中断风险手段的作用。企业日益认识到，在更靠近终端市场的地方采购或生产可以减少前置作业时间波动，并起到缓衝关税突然上涨的作用，同时，企业也越来越重视区域生产能力，将其视为一种风险管理资产。

基于细分的详细分析，将固化剂的化学性质、应用要求、最终用途产业要求和物理形态选择连结起来，以帮助制定配方和采购决策。

要了解市场，需要从细分观点固化剂的化学性质与其应用、终端用户产业和物理形态联繫起来，因为每个维度都存在独特的技术和商业性限制。根据固化剂的类型，该行业涵盖了酸酐、异氰酸酯、酚类和多胺类等化学性质。酸酐分为甲基六氢邻苯二甲酸酐、纳迪克甲基酸酐和邻苯二甲酸酐，每种酸酐具有独特的反应活性和热性能，使其适用于特定的树脂系统和固化条件。异氰酸酯又分为MDI和TDI，它们在官能基和应用适用性方面有所不同，在聚氨酯系统中发挥着核心作用，因为聚氨酯系统的刚度、柔软性和固化速度需要进行精细的平衡。酚类化合物，包括酚醛树脂和可溶酚醛树脂树脂，具有优异的耐热性和耐溶剂性，适用于高温涂料和复合材料基体应用；而聚胺，包括脂族胺、芳香族胺和环状脂族胺胺，具有广泛的固化速率和适用期，可用于黏合剂、涂料和浇铸配方。

区域比较分析显示美洲、欧洲、中东和非洲以及亚太地区的趋势如何影响固化剂产业的供应链、法规和技术采用。

区域趋势对固化剂市场的整体竞争地位、供应链韧性和创新轨迹有显着影响。在美洲，製造商和目的地受益于成熟的化学品生产基础设施以及接近性大规模汽车、航太和电子市场的地理优势。该地区支援快速的产品上市週期，并促进原材料供应商和原始设备製造商 (OEM) 之间的合作关係。然而，该地区的优先事项还包括将生产转移到国内以及製定库存策略，以降低海上运输中断和贸易波动带来的风险，这些因素会影响供应商的选择和投资规划。

深入了解技术领先地位、专业创新和整合技术服务如何决定供应商选择中的竞争地位和长期客户关係。

固化剂产业的竞争动态呈现出多元化的特点，既有跨国化工製造商，也有专业配方商和利基创新企业，它们各自凭藉技术实力、规模优势和紧密的客户关係展开竞争。领先的供应商透过丰富的产品系列、强大的应用工程能力以及支援准时交货和技术服务的全球物流网路来脱颖而出。这些能力对于那些需要在规模化生产过程中快速解决问题、需要针对特定基材定製配方或需要受监管行业检验的性能数据的客户至关重要。

为领导者提供切实可行的策略建议，以协调研发、采购、永续发展和商业职能，从而实现以绩效为导向且具韧性的价值。

产业领导企业可以透过在创新、供应链、商业和监管等领域采取有针对性的倡议，将不断变化的产业格局转化为竞争优势。首先，他们应优先制定产品组合策略，将固化化学与电动动力传动系统、航太复合材料和先进电子产品等高成长应用领域结合。这需要集中投入研发，以优化反应特性并检验其在特定应用应力条件下的性能，从而加速原始设备製造商 (OEM) 和一级供应商的采用。

一种透明且可重复的研究途径，结合了初步访谈、技术文献整合、产业分析和情境建模，以支持策略洞察。

本分析的调查方法融合了定性和定量方法，旨在对固化剂的现状形成可靠且基于实证的理解。关键资料来源包括对配方、研发、采购和终端用户等领域的技术负责人进行结构化访谈，从而获得关于性能要求、采购政策和新兴应用需求的第一手资讯。此外，本研究还辅以技术文献综述、专利分析和监管文件，以检验技术趋势和合规性考量。

简明扼要地总结了绩效要求、供应弹性和监管措施如何相互交织，从而界定竞争优势和策略重点。

总之，固化剂市场格局的特点是技术要求不断提高、监管日益复杂以及供应链重组。积极调整其化学产品系列相关人员主导应用性能要求、投资于永续数位化开发流程并增强供应链韧性的利益相关者，将能够获得差异化价值。在这个性能、可靠性和合规应对力至关重要的市场中，配方创新、区域生产策略和高度灵活的商业模式的相互作用将决定最终的赢家。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：硬化剂市场－依硬化剂类型划分

  • 酸酐
    • 甲基六氢邻苯二甲酸酐
    • 纳迪克甲基酐
    • 邻苯二甲酸酐
  • 异氰酸酯
    • MDI
    • TDI
  • 酚类
    • 诺沃拉克
    • 可溶酚醛树脂
  • 多胺
    • 脂族胺
    • 芳香胺
    • 脂族胺

第九章：固化剂市场：依应用领域划分

  • 黏合剂
  • 铸件
  • 涂层
  • 复合材料
  • 电子设备

第十章：固化剂市场：依最终用途产业划分

  • 航太
  • 车
  • 建造
  • 电气和电子
  • 船

第十一章：固化剂市场：以剂型划分

  • 液体
  • 粉末
  • 固体的

第十二章：硬化剂市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：固化剂市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：硬化剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国硬化剂市场

第十六章：中国硬化剂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aditya Birla Group
  • Air Products and Chemicals Inc
  • Akzo Nobel NV
  • Albemarle Corporation
  • Allnex Belgium SA
  • Arkema SA
  • Ashland Global Holdings Inc
  • Atul Ltd
  • BASF SE
  • Cardolite Corporation
  • Covestro AG
  • DIC Corporation
  • Dow Inc
  • Evonik Industries AG
  • Gabriel Performance Products
  • Hexion Inc
  • Huntsman Corporation
  • Incorez Ltd
  • Kukdo Chemical Co Ltd
  • LANXESS AG
  • Mitsubishi Chemical Corporation
  • Momentive Performance Materials Inc
  • Olin Corporation
  • Reichhold LLC
  • Wanhua Chemical Group Co Ltd
Product Code: MRR-4659C8712BC6

The Curing Agent Market was valued at USD 8.87 billion in 2025 and is projected to grow to USD 9.24 billion in 2026, with a CAGR of 5.82%, reaching USD 13.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.87 billion
Estimated Year [2026] USD 9.24 billion
Forecast Year [2032] USD 13.19 billion
CAGR (%) 5.82%

An authoritative introduction that frames curing agent chemical evolution, application imperatives, supply chain influences, and strategic priorities shaping industry decisions

The curing agent landscape is defined by a convergence of chemical innovation, application-driven performance demands, and evolving regulatory and trade environments. Over recent years, manufacturers and formulators have increasingly oriented their strategies around the need for faster cure schedules, enhanced thermal and mechanical performance, and greater environmental compliance. This environment has stimulated incremental product differentiation across core curing chemistries and has intensified the focus on application-specific formulations, whether for coatings that require tougher chemical resistance, adhesives that demand improved bond durability, or composite matrices that must balance processing window and end-use properties.

At the same time, advancements in polymer science and catalyst technologies have expanded the design space available to chemists, enabling finer control over cure kinetics and network architecture. These technical developments are complemented by shifts in end-use sectors that place premium value on weight savings, electrical performance, and longevity-factors that are especially pronounced in aerospace, automotive electrification, and advanced electronics. Consequently, stakeholders from raw material suppliers to OEMs are increasingly assessing curing agents not only for immediate functionality but also for lifecycle performance, recyclability, and compatibility with next-generation substrates.

In parallel, supply chain dynamics and trade policy have influenced procurement strategies and risk tolerance, prompting firms to reassess sourcing geographies and vendor portfolios. This introduction establishes the foundational context for a deeper examination of transformative market shifts, tariff impacts, segmentation-driven insights, regional comparisons, competitive positioning, and recommended actions tailored to industry leaders. The subsequent sections will synthesize these themes into actionable intelligence that supports decision-making across R&D, procurement, and corporate strategy functions.

A forward-looking synthesis of technological, regulatory, and supply chain accelerants that are collectively reshaping curing agent development, sourcing, and commercialization strategies

The curing agent sector is undergoing transformative shifts driven by technological, regulatory, and end-use transitions that together are rewriting traditional value chains. First, there is an intensified emphasis on performance optimization tied to electrification and lightweighting initiatives; formulations that deliver high thermal stability, enhanced adhesion to novel substrates, and shortened cure cycles are being prioritized. As a result, research and development pipelines now frequently target multifunctional chemistries and hybrid curing approaches that can meet stringent mechanical and thermal specifications while remaining compatible with modern manufacturing throughput constraints.

Secondly, sustainability and circularity considerations have moved from peripheral concerns to central design criteria. Manufacturers are adopting low-VOC and bio-derived precursor strategies, and there is heightened attention to end-of-life pathways and recyclability. Consequently, curing agents that facilitate lower energy curing profiles or that are derived from less hazardous feedstocks are attracting increased interest from both customers and regulators. This orientation is prompting suppliers to invest in greener synthesis routes and to validate environmental credentials through rigorous testing and documentation.

Thirdly, digitalization and advanced process control are changing how formulations are developed and deployed. Predictive modeling of cure kinetics, enabled by improved data capture and analytics, reduces development cycles and improves scale-up reliability. Adopters are leveraging these capabilities to shorten time-to-market for new formulations and to optimize production yields, thereby lowering total cost of ownership. Finally, geopolitical events and trade policy adjustments have accelerated supplier diversification and strategic inventory management, encouraging vertical integration in some parts of the supply chain. Taken together, these shifts are producing a more resilient, innovation-driven landscape where chemistry, sustainability, and digital capability determine competitive advantage.

A nuanced examination of cumulative tariff impacts through 2025 and how trade measures have compelled reshoring, sourcing substitutions, and adaptive innovation across the supply chain

Tariff actions and trade policy adjustments have become influential levers that affect raw material flows, procurement economics, and competitive positioning across the curing agent ecosystem. The policy changes implemented through 2025 have introduced reframed cost structures and prompted strategic responses from both suppliers and consumers. For many manufacturers, the heightened tariff environment has reinforced the importance of geographic diversification across supply bases and has elevated the role of nearshoring as a tool to mitigate exposure to transoceanic supply interruptions. Firms have increasingly evaluated regional production capability as a risk-management asset, recognizing that the ability to source or manufacture proximate to end-use markets can reduce lead-time volatility and provide buffering against sudden tariff escalations.

In parallel, tariff-driven cost pressures have encouraged reconfigurations of sourcing strategies that emphasize raw material substitution where technically feasible, longer-term supplier contracts to lock in pricing stability, and collaborative cost-sharing arrangements for qualifying high-volume buyers. These mechanisms have been complemented by industry efforts to optimize formulations to reduce dependence on the most tariff-sensitive feedstocks. At the same time, the tariff landscape has incentivized some suppliers to localize intermediate manufacturing to maintain price parity and customer loyalty in affected markets. Such localization often involves balancing capital expenditure against the anticipated duration and severity of trade measures, leading to a nuanced calculus around investment timing and scale.

Critically, trade policy changes have also had downstream effects on innovation timelines. When tariffs increase component costs, R&D priorities may shift toward developing more material-efficient systems or alternative curing chemistries that deliver equivalent performance with different raw material inputs. Conversely, stable trade conditions have the potential to accelerate collaborative innovation across borders by reducing the transactional friction associated with cross-border material flows. In summary, the cumulative tariff environment through 2025 has prompted adaptive strategies across procurement, manufacturing footprint, and product development that collectively alter competitive dynamics and the pace of technological adoption.

A detailed segmentation-driven analysis linking curing chemistries, application demands, end-use industry requirements, and physical form choices to inform formulation and sourcing decisions

Understanding the market requires a segmentation lens that links curing chemistries to applications, end-use industries, and physical form factors because each dimension exerts distinct technical and commercial constraints. Based on curing agent type, the industry spans anhydride, isocyanate, phenolic, and polyamine chemistries. Anhydrides are differentiated into methylhexahydrophthalic anhydride, nadic methyl anhydride, and phthalic anhydride, each offering unique reactivity profiles and thermal performance that make them suitable for specific resin systems and cure regimes. Isocyanates subdivide into MDI and TDI, which differ in functionality and application suitability and play central roles in polyurethane systems where stiffness, flexibility, and cure speed are finely balanced. Phenolic systems, including novolac and resole types, bring thermal resistance and solvent tolerance favored in high-temperature coatings and composite matrices, while polyamines-encompassing aliphatic amine, aromatic amine, and cycloaliphatic amine classes-provide a spectrum of cure kinetics and pot-life characteristics that are exploited across adhesives, coatings, and casting formulations.

When viewed through the application axis, key uses include adhesives, castings, coatings, composites, and electronics, each imposing distinct performance specifications that guide chemistry selection and formulation strategy. For instance, adhesives demand balanced adhesion to diverse substrates and often require curing agents that enable high bond strength with controlled shrinkage, whereas casting systems prioritize dimensional stability and thermal resistance. Coatings emphasize surface properties, weatherability, and processability, while composites require curing agents compatible with fiber reinforcements and capable of delivering the mechanical performance and thermal stability needed for weight-sensitive sectors. Electronics applications increasingly demand low ionic content, thermal management capabilities, and minimal outgassing, prompting selection of curing agents that meet stringent reliability criteria.

From the perspective of end-use industry segmentation-encompassing aerospace, automotive, construction, electrical and electronics, and marine-the performance envelope varies considerably. Aerospace formulators prioritize extreme thermal and fatigue performance, often leveraging high-performance phenolic or specialized anhydride systems. Automotive demand is driven by both structural adhesives for lightweighting and coating systems for durability and appearance, with electrification trends elevating needs for thermal conductivity and dielectric stability. Construction applications emphasize cost-effectiveness and long-term durability, while marine sectors require chemical resistance and UV stability. Electronics industries increasingly focus on miniaturization and thermal management, steering demand toward curing agents that provide reliable thermal interfaces and consistent dielectric behavior.

Finally, form factors-liquid, powder, and solid-shape logistics, processing, and end-use applicability. Liquids offer ease of mixing and are predominant in coatings and adhesives, powders provide dust-free handling and are favored for certain powder coating and composite prepreg applications, and solids may be used for preforms or specialized casting systems. The interplay among chemistry type, application, end-use requirements, and form factor creates a multidimensional decision matrix for formulators and procurement specialists, where trade-offs between performance, process efficiency, and cost must be navigated. This segmentation-driven view enables stakeholders to align product development and sourcing strategies with precise technical requirements and commercial constraints.

A regional comparative analysis showing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics shape supply chains, regulation, and technology adoption in curing agents

Regional dynamics profoundly influence competitive positioning, supply chain resilience, and innovation trajectories across the curing agent landscape. In the Americas, manufacturers and end users benefit from established chemical production infrastructure and proximity to large automotive, aerospace, and electronics markets. This geography supports rapid commercialization cycles and facilitates collaborative partnerships between raw material suppliers and OEMs. However, regional priorities also include onshoring initiatives and inventory strategies that mitigate exposure to ocean freight disruptions and trade volatility, which in turn shapes supplier selection and investment planning.

In Europe, the Middle East & Africa cluster, regulatory rigor and sustainability mandates are prominent drivers of product development. Stricter emissions and waste-management frameworks incentivize adoption of lower-VOC formulations and green chemistry pathways. Additionally, the presence of advanced aerospace and automotive supply chains in parts of Europe creates demand for high-performance curing agents with validated lifecycle credentials. The Middle East component of the region emphasizes feedstock availability and petrochemical integration, while select African markets are gradually increasing adoption in construction and infrastructure projects, albeit at variable pace.

Asia-Pacific represents a diverse and rapidly evolving landscape characterized by strong manufacturing capacity, expanding electronics and automotive hubs, and significant investments in advanced materials research. The region is a major consumer of curing chemistries for both large-volume industrial applications and specialized high-performance uses. Local supplier bases are expanding their technical portfolios to meet domestic demand and export opportunities, and policymakers' focus on industrial competitiveness and technology upgrading continues to influence capital allocation and R&D collaborations. Across these regions, differences in regulatory regimes, feedstock access, and end-market composition create distinct strategic imperatives for suppliers and buyers, necessitating region-specific approaches to production footprint, commercial engagement, and regulatory compliance.

An insightful look at competitive positioning where technology leadership, specialty innovation, and integrated technical services determine supplier preference and long-term customer ties

Competitive dynamics in the curing agent domain are shaped by a mix of multinational chemical producers, specialty formulators, and niche innovators who compete on the basis of technology, scale, and customer intimacy. Leading suppliers differentiate through deep product portfolios, application engineering capabilities, and global logistics networks that support just-in-time delivery and technical service. These capabilities prove critical for customers who require rapid troubleshooting during scale-up, tailored formulations for unique substrates, or validated performance data for regulated industries.

Simultaneously, specialist firms and startups are carving out positions by focusing on single-chemistry platforms, green synthesis routes, or advanced catalysts that accelerate cure or extend pot life. Their agility enables faster iteration cycles and closer partnerships with OEMs exploring novel composites or electronics packaging. Strategic collaborations between large incumbents and technology-focused smaller players are increasingly common, enabling incumbents to access innovation while offering scale and global market access to emerging technologies.

Across the competitive landscape, value is also being captured through services adjacent to the core chemistry offering. These include formulation advisory services, application-specific testing programs, and digital tools to model cure kinetics and performance under varying processing conditions. Providers that combine product excellence with consultative support create higher switching costs and deeper customer relationships. As procurement expectations evolve, suppliers that can demonstrate performance reliability, regulatory compliance, and supply continuity will secure preferential positions in long-term contracts and development partnerships.

Actionable strategic recommendations for leaders to align R&D, sourcing, sustainability, and commercial capabilities to capture performance-driven and resilience-focused value

Industry leaders can translate the evolving landscape into competitive advantage by pursuing targeted actions across innovation, supply chain, commercial, and regulatory domains. First, prioritize portfolio strategies that align curing chemistries with high-growth application areas such as electrified powertrains, aerospace composites, and advanced electronics. This requires focused R&D investments to tailor reactivity profiles and to validate performance under application-specific stressors, thereby accelerating acceptance by OEMs and tiered suppliers.

Second, strengthen supply chain resilience by diversifying feedstock sources and considering regional production or toll-manufacturing agreements that reduce exposure to trade disruptions. Complement these structural moves with contractual mechanisms-such as multi-year supply agreements and collaborative inventory management-to stabilize costs and guarantee availability for critical programs. In parallel, evaluate opportunities for backward integration or strategic partnerships that secure access to key intermediates.

Third, embed sustainability and regulatory readiness into product roadmaps. Invest in greener synthesis routes, substantiated life-cycle analyses, and transparent regulatory documentation to meet tightening environmental and customer standards. These investments will reduce regulatory risk and can unlock preference among customers seeking to decarbonize their supply chains. Fourth, adopt digital tools and modeling platforms to accelerate formulation development and scale-up. Predictive analytics and process simulation can shorten lead times and reduce trial-and-error in manufacturing transitions.

Finally, enhance go-to-market capabilities by coupling technical service with commercial flexibility. Offer value-added services such as application testing, co-development frameworks, and modular licensing models. This dual focus on technical excellence and customer enablement will deepen relationships, create barriers to substitution, and provide a platform for capturing premium pricing where validated performance advantages exist.

A transparent and reproducible research approach combining primary interviews, technical literature synthesis, trade analysis, and scenario modeling to underpin strategic findings

The research methodology underpinning this analysis integrates qualitative and quantitative approaches to produce a robust, evidence-based understanding of the curing agent landscape. Primary inputs include structured interviews with technical leaders across formulation, R&D, procurement, and end-user functions, which provide firsthand insights into performance requirements, sourcing preferences, and emerging application needs. These interviews are complemented by secondary technical literature reviews, patent analysis, and regulatory documentation to validate technological trends and compliance considerations.

Supply chain and trade dynamics were assessed through analysis of production footprints, shipping patterns, and publicly available trade policy announcements to identify how tariff shifts influence sourcing behavior and investment decisions. Competitive positioning insights were derived from company disclosures, product releases, and observed collaboration patterns, with particular attention to partnerships that accelerate commercialization of specialized chemistries. Scenario analysis was employed to examine the potential implications of varying trade and regulatory environments on procurement strategies and innovation timelines.

Throughout the research process, triangulation was used to reconcile divergent data points and to ensure the conclusions reflect a balanced synthesis of market perspectives. Care was taken to avoid overreliance on any single data source, and cross-validation techniques were applied to corroborate technical claims and reported strategic initiatives. The methodology emphasizes transparency, repeatability, and alignment with industry best practices for materials and chemical market intelligence.

A concise conclusion synthesizing how performance demands, supply resilience, and regulatory action converge to define competitive advantage and strategic priorities

In closing, the curing agent landscape is marked by accelerating technical demands, regulatory complexity, and supply chain reconfiguration. Stakeholders that proactively align chemistry portfolios with application-driven performance needs, invest in sustainable and digitally enabled development processes, and shore up supply chain resilience will be positioned to capture differentiated value. The interplay among formulation innovation, regional production strategy, and adaptive commercial models will determine winners in a market where performance, reliability, and regulatory readiness are paramount.

Looking ahead, the most consequential differentiators will be the ability to anticipate end-use transitions-such as electrification and lightweighting-and to rapidly translate those anticipated demands into validated, manufacturable formulations. Organizations that pair deep technical capability with agile sourcing and collaborative customer engagement will reduce time-to-adoption and increase the likelihood of securing long-term partnerships. Ultimately, the synthesis presented here is intended to equip decision-makers with the context and recommendations needed to prioritize investments, design resilient supply strategies, and pursue innovation pathways that align with evolving industry imperatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Curing Agent Market, by Curing Agent Type

  • 8.1. Anhydride
    • 8.1.1. Methylhexahydrophthalic Anhydride
    • 8.1.2. Nadic Methyl Anhydride
    • 8.1.3. Phthalic Anhydride
  • 8.2. Isocyanate
    • 8.2.1. MDI
    • 8.2.2. TDI
  • 8.3. Phenolic
    • 8.3.1. Novolac
    • 8.3.2. Resole
  • 8.4. Polyamine
    • 8.4.1. Aliphatic Amine
    • 8.4.2. Aromatic Amine
    • 8.4.3. Cycloaliphatic Amine

9. Curing Agent Market, by Application

  • 9.1. Adhesives
  • 9.2. Castings
  • 9.3. Coatings
  • 9.4. Composites
  • 9.5. Electronics

10. Curing Agent Market, by End Use Industry

  • 10.1. Aerospace
  • 10.2. Automotive
  • 10.3. Construction
  • 10.4. Electrical And Electronics
  • 10.5. Marine

11. Curing Agent Market, by Form

  • 11.1. Liquid
  • 11.2. Powder
  • 11.3. Solid

12. Curing Agent Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Curing Agent Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Curing Agent Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Curing Agent Market

16. China Curing Agent Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aditya Birla Group
  • 17.6. Air Products and Chemicals Inc
  • 17.7. Akzo Nobel N.V.
  • 17.8. Albemarle Corporation
  • 17.9. Allnex Belgium SA
  • 17.10. Arkema SA
  • 17.11. Ashland Global Holdings Inc
  • 17.12. Atul Ltd
  • 17.13. BASF SE
  • 17.14. Cardolite Corporation
  • 17.15. Covestro AG
  • 17.16. DIC Corporation
  • 17.17. Dow Inc
  • 17.18. Evonik Industries AG
  • 17.19. Gabriel Performance Products
  • 17.20. Hexion Inc
  • 17.21. Huntsman Corporation
  • 17.22. Incorez Ltd
  • 17.23. Kukdo Chemical Co Ltd
  • 17.24. LANXESS AG
  • 17.25. Mitsubishi Chemical Corporation
  • 17.26. Momentive Performance Materials Inc
  • 17.27. Olin Corporation
  • 17.28. Reichhold LLC
  • 17.29. Wanhua Chemical Group Co Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CURING AGENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CURING AGENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CURING AGENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CURING AGENT MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CURING AGENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CURING AGENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CURING AGENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CURING AGENT MARKET SIZE, BY ANHYDRIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CURING AGENT MARKET SIZE, BY ANHYDRIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CURING AGENT MARKET SIZE, BY ANHYDRIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CURING AGENT MARKET SIZE, BY METHYLHEXAHYDROPHTHALIC ANHYDRIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CURING AGENT MARKET SIZE, BY METHYLHEXAHYDROPHTHALIC ANHYDRIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CURING AGENT MARKET SIZE, BY METHYLHEXAHYDROPHTHALIC ANHYDRIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CURING AGENT MARKET SIZE, BY NADIC METHYL ANHYDRIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CURING AGENT MARKET SIZE, BY NADIC METHYL ANHYDRIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CURING AGENT MARKET SIZE, BY NADIC METHYL ANHYDRIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CURING AGENT MARKET SIZE, BY PHTHALIC ANHYDRIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CURING AGENT MARKET SIZE, BY PHTHALIC ANHYDRIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CURING AGENT MARKET SIZE, BY PHTHALIC ANHYDRIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CURING AGENT MARKET SIZE, BY ISOCYANATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CURING AGENT MARKET SIZE, BY ISOCYANATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CURING AGENT MARKET SIZE, BY ISOCYANATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CURING AGENT MARKET SIZE, BY MDI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CURING AGENT MARKET SIZE, BY MDI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CURING AGENT MARKET SIZE, BY MDI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CURING AGENT MARKET SIZE, BY TDI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CURING AGENT MARKET SIZE, BY TDI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CURING AGENT MARKET SIZE, BY TDI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CURING AGENT MARKET SIZE, BY PHENOLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CURING AGENT MARKET SIZE, BY PHENOLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CURING AGENT MARKET SIZE, BY PHENOLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CURING AGENT MARKET SIZE, BY NOVOLAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CURING AGENT MARKET SIZE, BY NOVOLAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CURING AGENT MARKET SIZE, BY NOVOLAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CURING AGENT MARKET SIZE, BY RESOLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CURING AGENT MARKET SIZE, BY RESOLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CURING AGENT MARKET SIZE, BY RESOLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CURING AGENT MARKET SIZE, BY POLYAMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CURING AGENT MARKET SIZE, BY POLYAMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CURING AGENT MARKET SIZE, BY POLYAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CURING AGENT MARKET SIZE, BY ALIPHATIC AMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CURING AGENT MARKET SIZE, BY ALIPHATIC AMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CURING AGENT MARKET SIZE, BY ALIPHATIC AMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CURING AGENT MARKET SIZE, BY AROMATIC AMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CURING AGENT MARKET SIZE, BY AROMATIC AMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CURING AGENT MARKET SIZE, BY AROMATIC AMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CURING AGENT MARKET SIZE, BY CYCLOALIPHATIC AMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CURING AGENT MARKET SIZE, BY CYCLOALIPHATIC AMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CURING AGENT MARKET SIZE, BY CYCLOALIPHATIC AMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CURING AGENT MARKET SIZE, BY ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CURING AGENT MARKET SIZE, BY ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CURING AGENT MARKET SIZE, BY ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CURING AGENT MARKET SIZE, BY CASTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CURING AGENT MARKET SIZE, BY CASTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CURING AGENT MARKET SIZE, BY CASTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CURING AGENT MARKET SIZE, BY COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CURING AGENT MARKET SIZE, BY COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CURING AGENT MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CURING AGENT MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CURING AGENT MARKET SIZE, BY COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CURING AGENT MARKET SIZE, BY COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRONICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRONICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRONICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CURING AGENT MARKET SIZE, BY AEROSPACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CURING AGENT MARKET SIZE, BY AEROSPACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CURING AGENT MARKET SIZE, BY AEROSPACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CURING AGENT MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CURING AGENT MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CURING AGENT MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CURING AGENT MARKET SIZE, BY CONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CURING AGENT MARKET SIZE, BY CONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CURING AGENT MARKET SIZE, BY CONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRICAL AND ELECTRONICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRICAL AND ELECTRONICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRICAL AND ELECTRONICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CURING AGENT MARKET SIZE, BY MARINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CURING AGENT MARKET SIZE, BY MARINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CURING AGENT MARKET SIZE, BY MARINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CURING AGENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CURING AGENT MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CURING AGENT MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CURING AGENT MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CURING AGENT MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CURING AGENT MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CURING AGENT MARKET SIZE, BY SOLID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CURING AGENT MARKET SIZE, BY SOLID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CURING AGENT MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CURING AGENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CURING AGENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CURING AGENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 174. GCC CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 179. GCC CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 206. G7 CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 215. NATO CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 218. NATO CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)